Literature DB >> 17613262

Steroid hormone control of myometrial contractility and parturition.

Sam Mesiano1, Toni N Welsh.   

Abstract

The precise temporal control of uterine contractility is essential for the success of pregnancy. For most of pregnancy, progesterone acting through genomic and non-genomic mechanisms promotes myometrial relaxation. At parturition the relaxatory actions of progesterone are nullified and the combined stimulatory actions of estrogens and other factors such as myometrial distention and immune/inflammatory cytokines, transform the myometrium to a highly contractile and excitable state leading to labor and delivery. This review addresses current understanding of how progesterone and estrogens affect the contractility of the pregnancy myometrium and how their actions are coordinated and controlled as part of the parturition cascade.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613262     DOI: 10.1016/j.semcdb.2007.05.003

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  44 in total

1.  Depletion of calcium stores contributes to progesterone-induced attenuation of calcium signaling of G protein-coupled receptors.

Authors:  Katja Gehrig-Burger; Jirina Slaninova; Gerald Gimpl
Journal:  Cell Mol Life Sci       Date:  2010-04-08       Impact factor: 9.261

Review 2.  Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit.

Authors:  Hitoshi Ishimoto; Robert B Jaffe
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

Review 3.  Molecular Regulation of Parturition: A Myometrial Perspective.

Authors:  Nora E Renthal; Koriand'r C Williams; Alina P Montalbano; Chien-Cheng Chen; Lu Gao; Carole R Mendelson
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-03       Impact factor: 6.915

4.  A molecular signature of an arrest of descent in human parturition.

Authors:  Pooja Mittal; Roberto Romero; Adi L Tarca; Sorin Draghici; Chia-Ling Nhan-Chang; Tinnakorn Chaiworapongsa; John Hotra; Ricardo Gomez; Juan Pedro Kusanovic; Deug-Chan Lee; Chong Jai Kim; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2011-02       Impact factor: 8.661

Review 5.  Central and peripheral neuroimmune responses: hyporesponsiveness during pregnancy.

Authors:  Sarah J Spencer; Abdeslam Mouihate; Michael A Galic; Quentin J Pittman
Journal:  J Physiol       Date:  2007-10-18       Impact factor: 5.182

Review 6.  Synthetic cannabinoids and potential reproductive consequences.

Authors:  Xiaofei Sun; Sudhansu K Dey
Journal:  Life Sci       Date:  2013-07-01       Impact factor: 5.037

Review 7.  Novel insights into molecular mechanisms of abruption-induced preterm birth.

Authors:  Catalin S Buhimschi; Frederik Schatz; Graciela Krikun; Irina A Buhimschi; Charles J Lockwood
Journal:  Expert Rev Mol Med       Date:  2010-11-01       Impact factor: 5.600

8.  Decreased DNA Methylations at the Progesterone Receptor Promoter A Induce Functional Progesterone Withdrawal in Human Parturition.

Authors:  Xia Li; Cheng Chen; Hui Luo; Jennifer C van Velkinburgh; Bing Ni; Qing Chang
Journal:  Reprod Sci       Date:  2014-01-08       Impact factor: 3.060

9.  Nrk, an X-linked protein kinase in the germinal center kinase family, is required for placental development and fetoplacental induction of labor.

Authors:  Kimitoshi Denda; Kanako Nakao-Wakabayashi; Naoki Okamoto; Naomi Kitamura; Je-Young Ryu; Yoh-ichi Tagawa; Tomoko Ichisaka; Shinya Yamanaka; Masayuki Komada
Journal:  J Biol Chem       Date:  2011-06-29       Impact factor: 5.157

10.  Characterization of the myometrial transcriptome and biological pathways of spontaneous human labor at term.

Authors:  Pooja Mittal; Roberto Romero; Adi L Tarca; Juan Gonzalez; Sorin Draghici; Yi Xu; Zhong Dong; Chia-Ling Nhan-Chang; Tinnakorn Chaiworapongsa; Stephen Lye; Juan Pedro Kusanovic; Leonard Lipovich; Shali Mazaki-Tovi; Sonia S Hassan; Sam Mesiano; Chong Jai Kim
Journal:  J Perinat Med       Date:  2010-07-14       Impact factor: 1.901

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.